Back to News
Market Impact: 0.25

BAT announces management board changes as general counsel to step down

BTI
Management & GovernanceLegal & LitigationCompany FundamentalsCorporate Guidance & OutlookArtificial IntelligenceAnalyst InsightsInvestor Sentiment & Positioning
BAT announces management board changes as general counsel to step down

British American Tobacco (BAT) announced a significant leadership transition in its legal function, with Jerome Abelman, Director, Legal and General Counsel, set to retire on December 31, 2025, after 23 years with the company. Paul McCrory, currently Director, Corporate and Regulatory Affairs, will succeed Abelman effective January 1, 2026, with his current responsibilities transferring to Chief Corporate Officer Kingsley Wheaton. This planned succession ensures continuity in critical legal and regulatory oversight as BAT, which reported £25.9 billion in 2024 revenue, continues its strategic pivot towards smokeless products, targeting 50 million consumers by 2030 and 50% of revenue from these products by 2035.

Analysis

British American Tobacco (BATS) has announced a well-telegraphed, long-term succession plan for its Legal and General Counsel, signaling stability in a critical governance function. The retirement of Jerome Abelman, effective at the end of 2025, will be followed by the appointment of internal candidate Paul McCrory, an 18-year company veteran currently serving on the Management Board. This internal promotion and the planned, multi-stage transition underscore an emphasis on continuity. The move is strategically significant as BAT, a company with £25.9 billion in 2024 revenue, navigates a complex global regulatory environment while pursuing an aggressive pivot to non-combustible products. The company's stated goals of reaching 50 million smokeless product consumers by 2030 and generating 50% of revenue from these products by 2035 hinge on effective legal and regulatory management. The CEO's confidence in McCrory's expertise in this specific area suggests the appointment is aligned with supporting this core strategic objective. This orderly transition in a non-CEO/CFO role is a low-impact event for the market but a positive indicator of sound corporate governance.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.